Specmed Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 17-12-2024
- Paid Up Capital ₹ 0.10 M
as on 17-12-2024
- Company Age 5 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 5.00 M
as on 17-12-2024
- Revenue 27.44%
(FY 2023)
- Profit -22797.29%
(FY 2023)
- Ebitda -7283.26%
(FY 2023)
- Net Worth -1413.19%
(FY 2023)
- Total Assets 43.09%
(FY 2023)
About Specmed Life Sciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹5.00 M.
Prashanth Rajanna and Abubacker Shafiq serve as directors at the Company.
- CIN/LLPIN
U51909KA2019PTC121099
- Company No.
121099
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Feb 2019
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangalore, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media
- Apps
Who are the key members and board of directors at Specmed Life Sciences?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Prashanth Rajanna  | Director | 05-Feb-2019 | Current |
| Abubacker Shafiq | Director | 05-Feb-2019 | Current |
Financial Performance of Specmed Life Sciences.
Specmed Life Sciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 27.44% increase. The company also saw a substantial fall in profitability, with a 22797.29% decrease in profit. The company's net worth observed a substantial decline by a decrease of 1413.19%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Specmed Life Sciences?
Unlock access to Specmed Life Sciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Specialist Health Systems Private LimitedActive 11 years 10 monthsPrashanth Rajanna and Abubacker Shafiq are mutual person
Trilife Health Systems Private LimitedActive 2 years 5 monthsPrashanth Rajanna and Abubacker Shafiq are mutual person
- Trilife Hospitality Services Private LimitedActive 5 months 26 days
Prashanth Rajanna and Abubacker Shafiq are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 20 Apr 2023 | ₹5.00 M | Open |
How Many Employees Work at Specmed Life Sciences?
Specmed Life Sciences has a workforce of 63 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Specmed Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Specmed Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
